DecisionDx®-SCC Significantly Improves Prediction Accur

DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Neck

Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC test in patients...

Related Keywords

New York , United States , Phoenix , Arizona , American , Castle Biosciences , Sherrif Ibrahim , American Joint Committee On Cancer Staging Manual , American College Of Mohs Surgery , Linkedin , National Comprehensive Cancer Network , Castle Biosciences Inc , Instagram , Facebook , Nasdaq , American College , Mohs Surgery , Annual Meeting , Rochester Dermatologic Surgery , Presenting Author , Sun Ballroom , Sheraton Phoenix Downtown , American Joint Committee , Cancer Staging Manual , Mypath Melanoma ,